Engineering <i>Escherichia coli</i>-Derived Nanoparticles for Vaccine Development
The development of effective vaccines necessitates a delicate balance between maximizing immunogenicity and minimizing safety concerns. Subunit vaccines, while generally considered safe, often fail to elicit robust and durable immune responses. Nanotechnology presents a promising approach to address...
Saved in:
| Main Authors: | Shubing Tang, Chen Zhao, Xianchao Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/12/11/1287 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Silico Development of a Multi-Epitope Subunit Vaccine against Bluetongue Virus in <i>Ovis aries</i> Using Immunoinformatics
by: Priyansha Raj Sinha, et al.
Published: (2024-10-01) -
Manipulating Intracellular Oxidative Conditions to Enhance Porphyrin Production in <i>Escherichia coli</i>
by: Bahareh Arab, et al.
Published: (2025-01-01) -
Mimicking Urinary Tract Infections Caused by Uropathogenic <i>Escherichia coli</i> Using a Human Three-Dimensional Tissue Engineering Model
by: Félix-Antoine Pellerin, et al.
Published: (2024-10-01) -
Fecal microbiome alterations of mice following immunization with gold nanoparticle vaccines against enterohemorrhagic Escherichia coli
by: Sarah Bowser, et al.
Published: (2024-12-01) -
A novel platform for engineered AAV-based vaccines
by: Sabrina Babutzka, et al.
Published: (2025-03-01)